1. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
2. FDA. KYPROLIS® (carfilzomib) for injection, for intravenous use 2012 [cited 2022 July/20]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202714s025lbl.pdf
3. FDA. NINLARO® (ixazomib) capsules, for oral use 2015 [cited 2022 July/20]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208462lbl.pdf
4. FDA. DARZALEX (daratumumab) injection, for intravenous use 2015 [cited 2022 July/20]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761036s004lbl.pdf
5. FDA. EMPLICITI (elotuzumab) for injection, for intravenous use 2015 [cited 2022 July/20]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/761035s000lbl.pdf